{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:18:09Z","timestamp":1793326689921,"version":"4.5.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"23","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1013362.02"],"award-info":[{"award-number":["1013362.02"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI119448"],"award-info":[{"award-number":["AI119448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["75N9301900065"],"award-info":[{"award-number":["75N9301900065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2021,11,9]]},"abstract":"<jats:p>The prevention of RVFV encephalitis requires intact adaptive immunity. In this study, we developed reagents to detect RVFV-specific T cells and provide evidence for Tfh cells and CD40\/CD40L interactions as critical mediators of this protection.<\/jats:p>","DOI":"10.1128\/jvi.01506-21","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T19:02:19Z","timestamp":1631127739000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40\/CD40L Interactions for Prevention of Encephalitis"],"prefix":"10.1128","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-5022","authenticated-orcid":true,"given":"Dominique J.","family":"Barbeau","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine, Department of Pediatrics, Division of Pediatric Infectious Disease, Pittsburgh, Pennsylvania, USA"},{"name":"University of Pittsburgh Center for Vaccine Research, Pittsburgh, Pennsylvania, USA"},{"name":"University of Pittsburgh, UPMC Children\u2019s Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-4838","authenticated-orcid":true,"given":"Haley N.","family":"Cartwright","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine, Department of Pediatrics, Division of Pediatric Infectious Disease, Pittsburgh, Pennsylvania, USA"},{"name":"University of Pittsburgh Center for Vaccine Research, Pittsburgh, Pennsylvania, USA"},{"name":"University of Pittsburgh, UPMC Children\u2019s Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Harmon","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Viral Special Pathogens Branch, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-0513","authenticated-orcid":true,"given":"Jessica R.","family":"Spengler","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Viral Special Pathogens Branch, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Viral Special Pathogens Branch, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sidney","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA"},{"name":"Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6764-7536","authenticated-orcid":true,"given":"Anita K.","family":"McElroy","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine, Department of Pediatrics, Division of Pediatric Infectious Disease, Pittsburgh, Pennsylvania, USA"},{"name":"University of Pittsburgh Center for Vaccine Research, Pittsburgh, Pennsylvania, USA"},{"name":"University of Pittsburgh, UPMC Children\u2019s Hospital, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.05.009"},{"key":"e_1_3_3_3_2","first-page":"114","article-title":"Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic","volume":"3","author":"Meegan JM","year":"1981","unstructured":"Meegan JM, Watten RH, Laughlin LW. 1981. Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic. Contr Epidem Biostatist 3:114\u2013123.","journal-title":"Contr Epidem Biostatist"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/378747"},{"key":"e_1_3_3_5_2","first-page":"183","article-title":"Clinical studies on Rift Valley fever. Part 2. Ophthalmologic and central nervous system complications","volume":"53","author":"Laughlin LW","year":"1978","unstructured":"Laughlin LW, Girgis NI, Meegan JM, Strausbaugh LJ, Yassin MW, Watten RH. 1978. Clinical studies on Rift Valley fever. Part 2. Ophthalmologic and central nervous system complications. J Egypt Public Health Assoc 53:183\u2013184.","journal-title":"J Egypt Public Health Assoc"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1003.020817"},{"key":"e_1_3_3_7_2","first-page":"867","article-title":"Rift Valley fever affecting humans in South Africa: a clinicopathological study","volume":"51","author":"van Velden DJ","year":"1977","unstructured":"van Velden DJ, Meyer JD, Olivier J, Gear JH, McIntosh B. 1977. Rift Valley fever affecting humans in South Africa: a clinicopathological study. S Afr Med J 51:867\u2013871.","journal-title":"S Afr Med J"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0318"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-015-0392-3"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-078154"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01962"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000949"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001529"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189250"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07543-8"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.05.012"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.08.016"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00337-13"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002874"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01270-18"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.3.1371-1377.2001"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1006"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-011-0513-0"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302101"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001421"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12945"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903207"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.18.10338"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170457"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083317"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3385"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0596-6"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.5.2129"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00936-07"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.01.046"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1046-2023(02)00349-3"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1803s100"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1997.0937"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01506-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01506-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T16:29:43Z","timestamp":1646497783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01506-21"}},"subtitle":[],"editor":[{"given":"Stacey","family":"Schultz-Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":40,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,11,9]]}},"alternative-id":["10.1128\/JVI.01506-21"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01506-21","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"2021-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01506-21"}}